By Shemona Safaya Biotechnology company Applied DNA Sciences has signed a five-year licensing and commercial-based agreement with apparel-textile manufacturer and sourcing firm Indus Group for CertainT's first large-scale deployment as a cotton traceability platform. Under the terms of the agreement Applied DNA will supply Indus with its CertainT platform for non-home, cotton-based products (apparel, [...]
STONY BROOK, N.Y. – July 29, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, will present a poster at the 4th Annual mRNA-based Therapeutics Summit taking place July 29 – 31, 2024, in Boston. The poster presents the Company’s Linea™ IVT platform – a combination [...]
STONY BROOK, N.Y. July 25, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced the signing of a five-year license and commercialization agreement for its CertainT® traceability platform (the “Agreement”) with Indus Group (“Indus”) a multinational apparel/textile manufacturing and sourcing company [...]
STONY BROOK, N.Y., July 18, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that the U.S. Defense Logistics Agency (DLA) exercised the first one-year option period of a three-year base contract with two one-year option periods entered into in May 2021. The contract supports DLA’s counterfeit [...]
STONY BROOK, N.Y., and JUPITER, FL – June 20, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a leader in PCR-based DNA technologies, and Alphazyme LLC (Alphazyme), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of specialty enzymes used in the life sciences sector, announced the successful conclusion of [...]
STONY BROOK, N.Y., June 18, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics subsidiary, Applied DNA Clinical Labs, LLC (ADCL), will utilize the GenXys Health Care Systems (GenXys) suite of clinical decision support software for interpretation and reporting [...]
STONY BROOK, N.Y. June 13, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced that the New York State Department of Health (“NYSDOH”) approved the Company’s TR8™ PGx (“TR8”) pharmacogenomic (PGx) testing service. The Company is currently in discussions to provide large-scale [...]
STONY BROOK, N.Y., June 5, 2024 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the “Company”), a leader in PCR-based DNA technologies, announced today that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application 18/302,247, entitled “Compositions and Methods for RNA [...]
Posted on May 28, 2024 By Lauren Schenkman About a third of positive-tested items had fibers solely from the banned region, despite U.S. regulations over forced labor concerns. Dive Brief: Cotton from the Xinjiang region of China was found in 19% of 822 cotton-containing products sampled from February 2023 to March 2024, according to a report [...]